Cargando…

Penkid: A Novel Biomarker of Reduced GFR in Sepsis

Detalles Bibliográficos
Autor principal:	Moledina, Dennis G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308914/ https://www.ncbi.nlm.nih.gov/pubmed/30596164 http://dx.doi.org/10.1016/j.ekir.2018.11.002

Ejemplares similares

Proenkephalin a 119–159 (penKid) – a novel biomarker for acute kidney injury in sepsis: an observational study
por: Rosenqvist, Mari, et al.
Publicado: (2019)

Proenkephalin A 119-159 (Penkid) Is an Early Biomarker of Septic Acute Kidney Injury: The Kidney in Sepsis and Septic Shock (Kid-SSS) Study
por: Hollinger, Alexa, et al.
Publicado: (2018)

Estimating GFR in the Elderly—New Approaches to an Old Problem
por: Pavkov, Meda E., et al.
Publicado: (2019)

Obesity-Related Glomerulopathy and Single-Nephron GFR
por: Denic, Aleksandar, et al.
Publicado: (2020)

Matrix metalloproteinases and their inhibitors: promising novel biomarkers in severe sepsis?
por: Hoffmann, Ursula, et al.
Publicado: (2009)

Age‐adapted eGFR thresholds underestimate the risks beyond kidney failure associated with CKD in older populations
por: Lees, Jennifer S., et al.
Publicado: (2022)

Is There Evidence of Any Safety Differences Among DPP-4 Inhibitors in the Treatment of People with Type 2 Diabetes Mellitus and Reduced GFR Due to Chronic Kidney Disease?
por: Evans, Marc, et al.
Publicado: (2015)

Biomarkers for late-onset neonatal sepsis
por: Polin, Richard A, et al.
Publicado: (2010)

Back-to-back comparison of penKID with NephroCheck® to predict acute kidney injury at admission in intensive care unit: a brief report
por: Gayat, Etienne, et al.
Publicado: (2018)

Apolipoprotein M - a new biomarker in sepsis
por: Christoffersen, Christina, et al.
Publicado: (2012)

Automated estimated GFR reporting: A new tool to promote safer prescribing in patients with chronic kidney disease?
por: Harris, KPG, et al.
Publicado: (2007)

Reduced cystatin C-estimated GFR and increased creatinine-estimated GFR in comparison with iohexol-estimated GFR in a hyperthyroid patient: A case report
por: Karawajczyk, Malgorzata, et al.
Publicado: (2008)

Rapid diagnosis of sepsis using biomarker signatures
por: Silman, Nigel James
Publicado: (2013)

Shedding metabo‘light’ on the search for sepsis biomarkers
por: dos Santos, Claudia C.
Publicado: (2015)

PSP/reg: a new stone in sepsis biomarkers?
por: Busani, Stefano, et al.
Publicado: (2012)

BTLA as a biomarker and mediator of sepsis-induced immunosuppression
por: Sherwood, Edward R, et al.
Publicado: (2013)

Hollinger A, Wittebole X, François B, et al. Proenkephalin A 119-159 (Penkid) is an early biomarker of septic acute kidney injury: the Kidney in Sepsis and Septic Shock (Kid-SSS) Study. Kidney Int Rep. 2018;3:1424–1433
Publicado: (2018)

Collagen-related biomarkers in severe sepsis: a big stretch?
por: Morrison, Gavin, et al.
Publicado: (2009)

Novel Filtration Markers for GFR Estimation
por: Karger, Amy B., et al.
Publicado: (2017)

Predicting outcome in patients with sepsis: new biomarkers for old expectations
por: Charles, Pierre-Emmanuel, et al.
Publicado: (2014)

Leptin in sepsis: a well-suited biomarker in critically ill patients?
por: Bracho-Riquelme, Rodolfo Leonel, et al.
Publicado: (2010)

Biomarkers in SIRS and sepsis: Quo vadis?
por: Novotny, Alexander R.
Publicado: (2010)

Separating signal from noise: the challenge of identifying useful biomarkers in sepsis
por: McCulloh, Russell J, et al.
Publicado: (2014)

Recently published papers: Sepsis – guidelines, treatment and novel approaches
por: Kalsi, Navneet, et al.
Publicado: (2008)

Improved estimation of glomerular filtration rate (GFR) by comparison of eGFR(cystatin C) and eGFR(creatinine)
por: Grubb, Anders, et al.
Publicado: (2012)

Finding new therapies for sepsis: the need for patient stratification and the use of genetic biomarkers
por: Hobson, Michael J, et al.
Publicado: (2011)

CXCR3 blockade: a novel anti-sepsis approach?
por: Delano, Matthew J, et al.
Publicado: (2012)

Heart Rate Variability: A Potential Noninvasive Biomarker in Viral Sepsis by COVID19 Infection
por: Moscote-Salazar, Luis Rafael, et al.
Publicado: (2020)

Assessing GFR With Proenkephalin
por: Beunders, Remi, et al.
Publicado: (2023)

The International Sepsis Forum's controversies in sepsis: how will sepsis be treated in 2051?
por: Marshall, John C
Publicado: (2002)

The International Sepsis Forum's controversies in sepsis: how will sepsis be treated in 2051?
por: Abraham, Edward
Publicado: (2002)

Interleukin-27: a potential new sepsis biomarker exposed through genome-wide transcriptional profiling
por: Scicluna, Brendon P, et al.
Publicado: (2012)

Death to sepsis: targeting apoptosis pathways in sepsis
por: Wheeler, Derek S
Publicado: (2009)

The International Sepsis Forum's frontiers in sepsis: high cardiac output should be maintained in severe sepsis
por: Vincent, Jean-Louis
Publicado: (2003)

The International Sepsis Forum's frontiers in sepsis: high cardiac output should not be maintained in severe sepsis
por: Sharma, Vinay K, et al.
Publicado: (2003)

Novel biomarkers in critical care: utility or futility?
por: Ackland, Gareth L, et al.
Publicado: (2007)

Steroid responses in sepsis: some novel thinking that may provide new insight
por: Deutschman, Clifford S
Publicado: (2013)

Urine sTREM-1 may be a valuable biomarker in diagnosis and prognosis of sepsis-associated acute kidney injury
por: Su, Longxiang, et al.
Publicado: (2015)

The challenge of sepsis
por: Levy, Mitchell M
Publicado: (2004)

The Surviving Sepsis Campaign sepsis change bundles and clinical practice
por: Dellinger, R Phillip, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_hc3p1fdr6trag9qnik06fucnso